AcelRx Pharmaceuticals, Inc. Securities Fraud Class Action
AcelRX Pharmaceuticals, Inc. Securities Fraud Investigation Shamis Gentile, a corporate securities fraud law firm, announces the investigation of a class action lawsuit on behalf of purchasers of the securities of AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX)...
Read More